Wound Care Biologics Market
Global Wound Care Biologics Market accounted for US$ 1.72 billion in 2020 and is estimated to be US$ 4.22 billion by 2030 and is anticipated to register a CAGR of 9.4%. Wound care biologics are bioengineered products that treat non-healing lower-extremity wounds. Wound care biologics entail the use of active biological agents such as antioxidant and antibacterial macromolecules originating from plants and animals. Wound care biologics are bioengineered materials that are used to treat non-healing lower-extremity lesions. They are utilised in post-surgery and trauma situations because they create a moist healing environment that aids in heat loss, protein absorption, and bacterial contamination prevention. In recent years, the use of biologics for wound care has increased dramatically.
The report " Global Wound Care Biologics Market, By Product Type (Biologic Skin Substitutes, Enzyme Based Formulations, and Growth factors), By Application (Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, and Pressure Ulcers) and Acute Wounds ( Surgical Wounds and Burns)), By End User (Hospital, Clinics, Ambulatory Surgical Centers, and Home Care Settings), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029’’
Key Highlights:
· In November 2021, Krystal Biotech Releases Positive Topline Results from the GEM-3 Pivotal Trial of VYJUVEKTM in Dystrophic Epidermolysis Bullosa Patients.
· In November 2021, Cook Biotech Inc. and Sanara MedTech Inc. have announced the commercial launch of two new innovative extracellular matrix products.
Analyst View:
Wound care biologics are being driven by an increase in the number of traumatic, surgical, ulcer, and burn wounds. Furthermore, the market for wound care biologics is being hampered by increased biologics costs and strict regulatory approvals for the launch of novel tissue engineered products. The expansion of this product segment is being driven by the increased incidence of difficult-to-heal wounds and their expanding adoption (thanks to their high efficacy).
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Wound Care Biologics Market, By Product Type (Biologic Skin Substitutes, Enzyme Based Formulations, and Growth factors), By Application (Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, and Pressure Ulcers) and Acute Wounds ( Surgical Wounds and Burns)), By End User (Hospital, Clinics, Ambulatory Surgical Centers, and Home Care Settings), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029”
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Wound-Care-Biologics-Market-284
Key Market Insights from the report:
Global Wound Care Biologics Market accounted for US$ 1.72 billion in 2020 and is estimated to be US$ 4.22 billion by 2030 and is anticipated to register a CAGR of 9.4%. Global Wound Care Biologics market is segmented into product type, application, end-user and region.
· Based on Product Type, the Global Wound Care Biologics Market is segmented into Biologic Skin Substitutes, Enzyme Based Formulations, and Growth factors.
· Based on Application, the Global Wound Care Biologics Market is segmented into Chronic Wounds (Diabetic Foot Ulcers, Venous Leg Ulcers, and Pressure Ulcers) and Acute Wounds ( Surgical Wounds and Burns).
· Based on End-user, the Global Wound Care Biologics Market is segmented into Hospital, Clinics, Ambulatory Surgical Centers, and Home Care Settings.
· By Region, the Global Wound Care Biologics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is dominating the global laser capture micro-dissection market due to availability of skilled personnel.
Competitive Landscape & their strategies of Global Wound Care Biologics Market:
The key players in the global Wound Care Biologics market includes Carl Zeiss AG, Molecular Machines & Industries, Ocimum Biosolutions LLC, Leica Microsystems, Danaher Corporation, Thermo Fisher Scientific, Indivumed GmbH, AvanSci Bio, L.L.C, Theranostics Health, and 3DHISTECH Ltd..
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
